Skip to main content

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investor Securities Class Action Lawsuit 04/28/2023

  • If you purchased a significant amount of shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, and / or if you purchased any NASDAQ: FULC shares prior to March 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. NASDAQ: FULC investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 29, 2023 - An amended complaint was filed. April 28, 2023 - An investor in shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Fulcrum Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between March 3, 2022...

You must register (for free) or login to view the entire case.